/Investor DB

DigiTx Partners LLC — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Cleerlycleerly.comin𝕏Jul 2022

Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.

AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US

James Min, MD(Founder)inJames K. Min(Founder)

BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)inLouis Samson(Director)

Co-investorsBattery VenturesBreyer CapitalCatalytic Impact FoundationEsplanade VenturesInsight PartnersLRVHealth+6 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.